← Open Payments lookup

DAVID NOVER: Open Payments

NPI 1922046861 · WARRINGTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$14,265 in 54 payments from 13 companies in 2025. Trend: 2023 $10,962 · 2024 $18,296 · 2025 $14,265

Honoraria: $11,825Food & beverage: $1,583Travel & lodging: $857
CompanyPaymentsAmount
Axsome Therapeutics, Inc.18$13,306
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$198
Otsuka America Pharmaceutical, Inc.5$177
Supernus Pharmaceuticals, Inc.3$141
Collegium Pharmaceutical, Inc.5$112
Takeda Pharmaceuticals U.S.A., Inc.3$68
E.R. Squibb & Sons, L.L.C.3$65
Lundbeck LLC3$63
ABBVIE INC.3$48
Alkermes, Inc.2$36

Products named: Auvelity, REXULTI, CAPLYTA, Qelbree, Jornay PM, TRINTELLIX, COBENFY, VRAYLAR.

Industry payments across PA — which companies pay providers there.